Bio-Rad Laboratories, Inc. (BIO) Operating cash flow 2016–2025
Bio-Rad Laboratories, Inc. (BIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$532.2MFY2025 · since FY2016: $216.1M → $532.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $532.2M | +16.9% |
| FY2024 | $455.2M | +21.4% |
| FY2023 | $374.9M | +92.8% |
| FY2022 | $194.4M | -71.0% |
| FY2021 | $669.5M | +14.4% |
| FY2020 | $585.0M | +27.8% |
| FY2019 | $457.9M | +60.4% |
| FY2018 | $285.5M | +174.2% |
| FY2017 | $104.1M | -51.8% |
| FY2016 | $216.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice